Newsmeme!
Discover News you didn't know existed
Inflammation
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Specialised Symposium On Diabetic Microandiopathy Featured At 60th Annual British Microcirculation Society Meeting
Published February 10, 2010, 5:44 am, Medical News Today
Delegates from all over the world will attend the 60th Annual British Microcirculation Society Meeting (ABMSM), which is to be held at the Peninsula Medical School in Exeter on 19th and 20th April this year. The British Microcirculation Society has a membership of over 250 scientists, academics and clinicians with an interest in the circulation of blood and other tissue fluids in smaller vessels ...
Early life stress may cause cardiac disease
Published February 10, 2010, 5:37 am, MalaysiaNews.net
Washington, Feb 10 (IANS) Early life stress is likely to be a risk factor for cardiovascular disease in adulthood, researchers suggest.
Maternal obesity ups risk of heart disease in offspring
Published February 10, 2010, 5:37 am, MalaysiaNews.net
Washington, Feb 10 (IANS) Maternal obesity dramatically increases the risk of inflammation-related diseases like heart disease, stroke and others in the offspring, a study says.
Portola Pharmaceuticals Announces Late-Breaker Presentation on Betrixaban at American College of Cardiology's 59th ...
Published February 10, 2010, 5:30 am, PR Newswire via Yahoo! Finance
Portola Pharmaceuticals, Inc. today announced that results from its Phase 2 EXPLORE-Xa clinical trial of betrixaban, an investigational oral direct Factor Xa inhibitor anticoagulant, will be presented during a late-breaking results session at the American College of Cardiology's 59th Annual Scientific Session in Atlanta in March.
Non-Hospitalised Patients With Active Inflammatory Bowel Disease Are 16 Times More Likely To Suffer A Blood Clot Than ...
Published February 10, 2010, 4:45 am, Medical News Today
Non-hospitalised patients with active inflammatory bowel disease (IBD) are 16 times more likely to suffer a blood clot (venous thromboembolism) than the non-hospitalised general population. These results suggest that active IBD in ambulatory patients might be a far greater risk factor for venous thromboembolism than previously recognised, and these patients could be a target for prophylaxis ...
Women With Gout At Greater Risk Of Heart Attack Than Men
Published February 10, 2010, 4:44 am, Medical News Today
Women with gout are at greater risk of a heart attack than men with the disease, indicates research published ahead of print in the Annals of the Rheumatic Diseases. Gout is known to boost the risk of a heart attack in men. But to date, little has been known about the impact of gout on women's cardiovascular health. Gout is common and caused by inflammation in the joints as a result of excess ...
US FDA Approves New Indication For CRESTOR® (Rosuvastatin Calcium)
Published February 10, 2010, 4:43 am, Medical News Today
AstraZeneca (NYSE: AZN) announced that the US Food and Drug Administration (FDA) has approved CRESTOR® (rosuvastatin calcium) to reduce the risk of stroke, myocardial infarction (heart attack) and arterial revascularization procedures in individuals without clinically evident coronary heart disease but with an increased risk of cardiovascular disease (CVD) based on age (men 50 and over, women 60 ...
Pharmaceutical firm posts loss
Published February 10, 2010, 4:30 am, Belfast Telegraph
Irish pharmaceutical company Elan has slumped to a fourth quarter loss, but bosses remain confident the firm will bounce back in the next 12 months as sales for its multiple sclerosis drug, Tysabri, grow. Related Stories Murder probe after boy found dead Train passengers left stranded Luxury loo roll contains cashmere Curry poisoner faces life sentence Five new cancer centres to open
A common cholesterol drug fights cataracts, too
Published February 10, 2010, 4:07 am, PhysOrg
Statins, a class of drugs used to lower cholesterol levels, have been successfully fighting heart disease for years. A new study from Tel Aviv University has now found that the same drugs cut the risks of cataracts in men by almost 40%.
QR Pharma commences clinical trial of Posiphen in early stage AD patients
Published February 10, 2010, 3:56 am, News-Medical-Net
QR Pharma, Inc. (QR), a developer of novel drugs to treat Alzheimer’s disease (AD), announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |